Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L

doi:10.1084/jem.183.4.1331

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Bevec, T.
	Articles by Turk, V.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Bevec, T.
	Articles by Turk, V.


Social Bookmarking

	What's this?

ARTICLES

Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L

T Bevec, V Stoka, G Pungercic, I Dolenc and V Turk
Department of Biochemistry and Molecular Biology, Jozef Stefan Institute, Ljubljana, Slovenia.

The invariant chain (Ii) is associated with major histocompatibility complex class II molecules during early stages of their intracellular transport. In an acidic endosomal/lysosomal compartment, it is proteolytically cleaved and removed from class II heterodimers. Participation of aspartic and cysteine proteases has been observed in in vitro degradation of Ii, but the specific enzymes responsible for its in vivo processing are as yet undefined. We have previously isolated a noncovalent complex of the lysosomal cysteine protease cathepsin L with a peptide fragment derived from the p41 form of Ii from human kidney. Here we show that this Ii fragment, which is identical to the alternatively spliced segment of p41, is a very potent competitive inhibitor of cathepsin L (equilibrium inhibition constant Ki = 1.7 X 10(-12) M). It inhibits two other cysteine proteases, cathepsin H and papain, but to much lesser extent. Cysteine proteases cathepsins B, C, and S, as well as representatives of serine, aspartic, and metalloproteases, are not inhibited at all. These findings suggest a novel role for p41 in the regulation of various proteolytic activities during antigen processing and presentation. The Ii inhibitory fragment shows no sequence homology with the known cysteine protease inhibitors, and may, therefore, represent a new class.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Mihelic, M., Dobersek, A., Guncar, G., Turk, D. (2008). Inhibitory Fragment from the p41 Form of Invariant Chain Can Regulate Activity of Cysteine Cathepsins in Antigen Presentation. J. Biol. Chem. 283: 14453-14460 [Abstract] [Full Text]
Novinec, M., Grass, R. N., Stark, W. J., Turk, V., Baici, A., Lenarcic, B. (2007). Interaction between Human Cathepsins K, L, and S and Elastins: MECHANISM OF ELASTINOLYSIS AND INHIBITION BY MACROMOLECULAR INHIBITORS. J. Biol. Chem. 282: 7893-7902 [Abstract] [Full Text]
Novinec, M., Kordis, D., Turk, V., Lenarcic, B. (2006). Diversity and Evolution of the Thyroglobulin Type-1 Domain Superfamily. Mol Biol Evol 23: 744-755 [Abstract] [Full Text]
Sevilla, L. M., Comstock, S. S., Swier, K., Miller, J. (2004). Endoplasmic Reticulum-Associated Degradation-Induced Dissociation of Class II Invariant Chain Complexes Containing a Glycosylation-Deficient Form of p41. J. Immunol. 173: 2586-2593 [Abstract] [Full Text]
Nolan, K. F., Strong, V., Soler, D., Fairchild, P. J., Cobbold, S. P., Croxton, R., Gonzalo, J.-A., Rubio, A., Wells, M., Waldmann, H. (2004). IL-10-Conditioned Dendritic Cells, Decommissioned for Recruitment of Adaptive Immunity, Elicit Innate Inflammatory Gene Products in Response to Danger Signals. J. Immunol. 172: 2201-2209 [Abstract] [Full Text]
Ebert, D. H., Kopecky-Bromberg, S. A., Dermody, T. S. (2004). Cathepsin B Is Inhibited in Mutant Cells Selected during Persistent Reovirus Infection. J. Biol. Chem. 279: 3837-3851 [Abstract] [Full Text]
Khalil, H., Brunet, A., Saba, I., Terra, R., Sekaly, R. P., Thibodeau, J. (2003). The MHC class II {beta} chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal. Int Immunol 15: 1249-1263 [Abstract] [Full Text]
Ye, Q., Finn, P. W., Sweeney, R., Bikoff, E. K., Riese, R. J. (2003). MHC Class II-Associated Invariant Chain Isoforms Regulate Pulmonary Immune Responses. J. Immunol. 170: 1473-1480 [Abstract] [Full Text]
Beers, C., Honey, K., Fink, S., Forbush, K., Rudensky, A. (2003). Differential Regulation of Cathepsin S and Cathepsin L in Interferon {gamma}-treated Macrophages. J. Exp. Med. 197: 169-179 [Abstract] [Full Text]
Trgovcich, J., Johnson, D., Roizman, B. (2002). Cell Surface Major Histocompatibility Complex Class II Proteins Are Regulated by the Products of the {gamma}134.5 and UL41 Genes of Herpes Simplex Virus 1. J. Virol. 76: 6974-6986 [Abstract] [Full Text]
Engering, A., Pieters, J. (2001). Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells. Int Immunol 13: 127-134 [Abstract] [Full Text]
Pierre, P., Shachar, I., Matza, D., Gatti, E., Flavell, R. A., Mellman, I. (2000). Invariant Chain Controls H2-M Proteolysis in Mouse Splenocytes and Dendritic Cells. J. Exp. Med. 191: 1057-1062 [Abstract] [Full Text]
Hwa, V., Oh, Y., Rosenfeld, R. G. (1999). The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily. Endocr. Rev. 20: 761-787 [Abstract] [Full Text]
Eynon, E. E., Schlax, C., Pieters, J. (1999). A Secreted Form of the Major Histocompatibility Complex Class II-associated Invariant Chain Inhibiting T Cell Activation. J. Biol. Chem. 274: 26266-26271 [Abstract] [Full Text]
Lenarcic, B., Turk, V. (1999). Thyroglobulin Type-1 Domains in Equistatin Inhibit Both Papain-like Cysteine Proteinases and Cathepsin D. J. Biol. Chem. 274: 563-566 [Abstract] [Full Text]
Soos, J. M., Morrow, J., Ashley, T. A., Szente, B. E., Bikoff, E. K., Zamvil, S. S. (1998). Astrocytes Express Elements of the Class II Endocytic Pathway and Process Central Nervous System Autoantigen for Presentation to Encephalitogenic T Cells. J. Immunol. 161: 5959-5966 [Abstract] [Full Text]
Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J. A., Ploegh, H., Peters, C., Rudensky, A. Y. (1998). Cathepsin L: Critical Role in Ii Degradation and CD4 T Cell Selection in the Thymus. Science 280: 450-453 [Abstract] [Full Text]
Bikoff, E. K., Kenty, G., Van Kaer, L. (1998). Distinct Peptide Loading Pathways for MHC Class II Molecules Associated with Alternative Ii Chain Isoforms. J. Immunol. 160: 3101-3110 [Abstract] [Full Text]
Wang, K., Peterson, P. A., Karlsson, L. (1997). Decreased Endosomal Delivery of Major Histocompatibility Complex Class II-invariant Chain Complexes in Dynamin-deficient Cells. J. Biol. Chem. 272: 17055-17060 [Abstract] [Full Text]
Lenarcic, B., Ritonja, A., Turk, B., Turk, V. (1997). Equistatin, a New Inhibitor of Cysteine Proteinases from Actinia equina, Is Structurally Related to Thyroglobulin Type-1 Domain. J. Biol. Chem. 272: 13899-13903 [Abstract] [Full Text]
Lenarcic, B., Krishnan, G., Borukhovich, R., Ruck, B., Turk, V., Moczydlowski, E. (2000). Saxiphilin, a Saxitoxin-binding Protein with Two Thyroglobulin Type 1 Domains, Is an Inhibitor of Papain-like Cysteine Proteinases. J. Biol. Chem. 275: 15572-15577 [Abstract] [Full Text]
Honey, K., Duff, M., Beers, C., Brissette, W. H., Elliott, E. A., Peters, C., Maric, M., Cresswell, P., Rudensky, A. (2001). Cathepsin S Regulates the Expression of Cathepsin L and the Turnover of gamma -Interferon-inducible Lysosomal Thiol Reductase in B Lymphocytes. J. Biol. Chem. 276: 22573-22578 [Abstract] [Full Text]